Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hayandra Clinic is a prominent Indonesian biotechnology and healthcare provider specializing in regenerative medicine and advanced cell therapies. Based in Jakarta, the clinic is a leader in the clinical application of autologous adipose-derived stem cells (ADSCs) and immune cell treatments, including Natural Killer (NK) cell therapy. The organization operates its own specialized laboratory, HayandraLab, which focuses on the isolation and processing of the stromal vascular fraction (SVF) and expanded stem cells. Their clinical programs target a wide range of conditions such as osteoarthritis, diabetes mellitus, autoimmune disorders, and various aesthetic concerns. Hayandra Clinic is recognized for its commitment to research and has established collaborations with academic institutions and the Indonesian Ministry of Health to advance cell-based medical standards in the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hayandra Clinic.